Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Cornea Research Foundation of America (CRFA) is a non-profit clinical research organization dedicated to restoring sight through innovative corneal research and education. Founded in 1988 by Dr. Francis Price Jr., the foundation has pioneered transformative surgical techniques, including Descemet Membrane Endothelial Keratoplasty (DMEK) and Descemet Stripping Endothelial Keratoplasty (DSEK). CRFA manages one of the world's largest independent databases of corneal transplant outcomes, providing critical data on long-term graft survival and patient results. The organization also conducts clinical trials for new ophthalmic drugs, surgical devices, and regenerative therapies. Their mission extends to educating surgeons globally to improve the standard of care for patients with corneal diseases like Fuchs' dystrophy and keratoconus.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cornea Research Foundation of America.